A taste of things to come for EU medtech: 300 surprise inspections by notified body BSI
This article was originally published in SRA
Notified body BSI Group is planning to conduct up to 300 unannounced audits of medical device manufacturers globally this year, as part of its efforts to comply with new EU requirements designed to strengthen the safety of medical devices1.
You may also be interested in...
While the Dutch government negotiates an acceptable price for Leadiant Biosciences’ orphan drug CDCA, a university hospital has resumed supplying pharmacy compounded versions of the drug after addressing initial problems with the sourcing of raw materials.
The European Court of Justice has confirmed the European Medicines Agency’s approach to disclosure of data submitted as part of a marketing authorization application. It is a big disappointment for industry, which nonetheless says it supports responsible data sharing and will support efforts to develop a balanced approach.
An EU pilot project will assess whether there is sufficient demand from companies to obtain simultaneous scientific advice from EU national competent authorities.